dc.contributor.author |
Yagci, MA |
|
dc.contributor.author |
Tardu, A |
|
dc.contributor.author |
Karagul, S |
|
dc.contributor.author |
Ince, V |
|
dc.contributor.author |
Ertugrul, I |
|
dc.contributor.author |
Kirmizi, S |
|
dc.contributor.author |
Unal, B |
|
dc.contributor.author |
Aydin, C |
|
dc.contributor.author |
Kayaalp, C |
|
dc.contributor.author |
Yilmaz, S |
|
dc.date.accessioned |
2022-10-13T11:45:47Z |
|
dc.date.available |
2022-10-13T11:45:47Z |
|
dc.date.issued |
2015 |
|
dc.identifier.uri |
http://hdl.handle.net/11616/79160 |
|
dc.description.abstract |
Objectives. This study sought to evaluate the indications, techniques, and results of inferior vena cava (IVC) replacement at living donor liver transplantation (LDLT). |
|
dc.description.abstract |
Materials and Methods. We performed 821 LDLTs and 11 (1.3%) patients required concomitant IVC replacement. We analyzed the indications, replacement materials, and outcomes. |
|
dc.description.abstract |
Results. Right, left, and left lateral liver lobes were transplanted in 7, 2, and 2 patients, respectively. The indications for IVC replacement were thrombosis/fibrosis in 7 patients (Budd-Chiari 4, hereditary tyrosinemia 1, congenital hepatic fibrosis 1, cryptogenic 1), involvement with mass in 3 patients (Echinococcus alveolaris 2, hepatoblastoma 1) and iatrogenic narrowing at IVC in 1 patient. Cryopreserved grafts (aorta n = 5, IVC n = 4, iliac vein n = 1) or synthetic graft (n = 1) were used for replacements. In 1 patient, hepatic outflow obstruction developed at 39 days and was treated successfully by interventional radiology. There was only 1 hospital mortality (8.9%) that was unrelated to caval replacement (subarachnoid hemorrhage). Of the remaining patients, the caval grafts were patent after a mean 7.7 months of follow-up (range 1 to 17 months). |
|
dc.description.abstract |
Conclusions. Although rare, IVC replacement can be necessary at LDLT. Budd-Chiari and E. alveolaris are the main underlying diseases for replacement requirements. Caval replacement with cryopreserved vascular grafts can provide successful short-term and long-term patency. |
|
dc.description.abstract |
C1 [Yagci, M. A.; Tardu, A.; Karagul, S.; Ince, V.; Ertugrul, I.; Kirmizi, S.; Unal, B.; Aydin, C.; Kayaalp, C.; Yilmaz, S.] Inonu Univ, Dept Surg, Fac Med, TR-44315 Malatya, Turkey. |
|
dc.source |
TRANSPLANTATION PROCEEDINGS |
|
dc.title |
Living Donor Liver Transplantation With Vena Cava Replacement |
|